Intra-Cellular Therapies Inc. buy BiotechBee
Start price
24.06.23
/
70%
€58.60
Target price
30.06.26
€90.00
Performance (%)
18.43%
End price
19.02.24
€69.40
Summary
This prediction ended on 19.02.24 with a price of €69.40. The prediction had a final performance of 18.43%. BiotechBee has a follow-up prediction for Intra-Cellular Therapies Inc. where he still thinks Intra-Cellular Therapies Inc. is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intra-Cellular Therapies Inc. | -4.167% | -4.167% | 21.908% |
iShares Core DAX® | -3.033% | 0.651% | 12.268% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% |
According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy mit Kursziel 90,0
In the thread Trading Intra-Cellular Therapies Inc.
Buy beendet
Current prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.40
19.02.24
19.02.24
€85.00
30.09.25
30.09.25
-2.02%
19.07.24
19.07.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.49
23.09.22
23.09.22
€80.00
31.07.25
31.07.25
28.12%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year